Primary study · included by 1 review

Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.

Cui 2023 · Cui Huijie, Qu Yang, Zhang Li, et al. · International journal of cancer · 2023

Included by

Bladder cancer risk factors: a comprehensive umbrella review of meta-analyses.
Non-Cochrane · aetiology · 2026 · cited as Cui 2023 · Table 1 (Included MA); References
Outcome this study informsPooled effectEvidenceCertainty
Risk of bladder cancer
With overweight (BMI = >25 kg/m2) vs Without overweight (BMI = >25 kg/m2)
RR 1.06 [0.98, 1.15]23 studies · 33697415 participantsVery low
Risk of bladder cancer
ABO blood group AB vs ABO blood group O
HR 1.06 [0.95, 1.19]5 studies · 1946008 participantsVery low
Risk of bladder cancer
Early menopause vs Non-menopause
RR 1.22 [1.06, 1.40]7 studiesVery low
Risk of bladder cancer
ABO blood group B vs ABO blood group O
HR 1.09 [0.97, 1.23]5 studies · 1946008 participantsVery low
Risk of bladder cancer
Age at menarche vs Reference category per source meta-analysis
RR 0.96 [0.85, 1.08]12 studies · 1350207 participantsVery low
Risk of bladder cancer
ABO blood group A vs ABO blood group O
HR 1.12 [1.01, 1.23]5 studies · 1946008 participantsVery low

1 including review in total.